| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis
|
Jullien, V.
|
|
2007
|
64 |
1 |
p. 105-109
|
article
|
| 2 |
A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation
|
Conil, Jean Marie
|
|
2007
|
64 |
1 |
p. 27-35
|
article
|
| 3 |
Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey
|
Stewart, Derek
|
|
2007
|
64 |
1 |
p. 90-95
|
article
|
| 4 |
Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain?
|
Hughes, Jeff
|
|
2007
|
64 |
1 |
p. 83-89
|
article
|
| 5 |
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain
|
Forst, Thomas
|
|
2007
|
64 |
1 |
p. 75-82
|
article
|
| 6 |
Erratum
|
|
|
2007
|
64 |
1 |
p. 118
|
article
|
| 7 |
Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia
|
Tang, Yi-lang
|
|
2007
|
64 |
1 |
p. 49-56
|
article
|
| 8 |
Glimepiride-induced vasculitis: a case report
|
Ben Salem, Chaker
|
|
2007
|
64 |
1 |
p. 113-114
|
article
|
| 9 |
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects
|
Zhang, Yifan
|
|
2007
|
64 |
1 |
p. 67-74
|
article
|
| 10 |
John Trounce
|
Spector, Roy G.
|
|
2007
|
64 |
1 |
p. 116-117
|
article
|
| 11 |
No association between CYP2D6 polymorphisms and personality trait in Japanese
|
Iwashima, Kumiko
|
|
2007
|
64 |
1 |
p. 96-99
|
article
|
| 12 |
Off-label and unlicensed prescribing for children: have we made any progress?
|
Waller, D. G.
|
|
2007
|
64 |
1 |
p. 1-2
|
article
|
| 13 |
Oxford Handbook of Nurse Prescribing
|
|
|
2007
|
64 |
1 |
p. 115
|
article
|
| 14 |
Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or β-blockers and the risk of atherosclerosis
|
Schelleman, H.
|
|
2007
|
64 |
1 |
p. 57-66
|
article
|
| 15 |
Population pharmacokinetic and pharmacodynamic models of remifentanil in healthy volunteers using artificial neural network analysis
|
Kang, S. H.
|
|
2007
|
64 |
1 |
p. 3-13
|
article
|
| 16 |
Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease
|
Lehr, Thorsten
|
|
2007
|
64 |
1 |
p. 36-48
|
article
|
| 17 |
Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation
|
Moreno, Raul
|
|
2007
|
64 |
1 |
p. 110-112
|
article
|
| 18 |
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies –CYP2C9 and warfarin as an example
|
Dickinson, Gemma L.
|
|
2007
|
64 |
1 |
p. 14-26
|
article
|
| 19 |
Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes
|
Roughead, Elizabeth E.
|
|
2007
|
64 |
1 |
p. 100-104
|
article
|
Journal description